Tower Research Capital LLC (Trc) Emergent Bio Solutions Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 231 shares of EBS stock, worth $2,048. This represents 0.0% of its overall portfolio holdings.

Number of Shares

231

Previous 29,386 99.21%

Holding current value

$2,048

Previous $200,000 99.5%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$5.72 - $14.77 $166,766 - $430,619	-29,155 Reduced 99.21%	231 $1,000
Q2 2024 Aug 13, 2024	BUY	$1.86 - $6.98 $28,735 - $107,834	15,449 Added 110.85%	29,386 $200,000
Q1 2024 May 15, 2024	SELL	$1.5 - $3.41 $8,895 - $20,221	-5,930 Reduced 29.85%	13,937 $35,000
Q4 2023 Feb 13, 2024	BUY	$1.82 - $3.16 $12,417 - $21,560	6,823 Added 52.31%	19,867 $47,000
Q3 2023 Nov 14, 2023	SELL	$3.17 - $7.91 $7,918 - $19,759	-2,498 Reduced 16.07%	13,044 $44,000
Q2 2023 Aug 14, 2023	BUY	$7.35 - $13.21 $48,458 - $87,093	6,593 Added 73.67%	15,542 $114,000
Q1 2023 May 09, 2023	SELL	$7.79 - $16.29 $42,587 - $89,057	-5,467 Reduced 37.92%	8,949 $93,000
Q4 2022 Feb 10, 2023	BUY	$11.0 - $21.45 $128,876 - $251,308	11,716 Added 433.93%	14,416 $170,000
Q3 2022 Nov 10, 2022	SELL	$20.09 - $35.8 $185,792 - $331,078	-9,248 Reduced 77.4%	2,700 $57,000
Q2 2022 Aug 15, 2022	BUY	$27.42 - $43.63 $289,747 - $461,038	10,567 Added 765.17%	11,948 $371,000
Q1 2022 May 12, 2022	SELL	$36.48 - $52.22 $575,581 - $823,927	-15,778 Reduced 91.95%	1,381 $57,000
Q4 2021 Feb 14, 2022	BUY	$33.11 - $55.01 $452,713 - $752,151	13,673 Added 392.23%	17,159 $746,000
Q3 2021 Nov 15, 2021	SELL	$50.07 - $66.05 $664,428 - $876,483	-13,270 Reduced 79.2%	3,486 $174,000
Q2 2021 Aug 16, 2021	BUY	$56.61 - $80.46 $655,940 - $932,290	11,587 Added 224.16%	16,756 $1.06 Million
Q1 2021 May 17, 2021	SELL	$86.23 - $125.19 $547,474 - $794,831	-6,349 Reduced 55.12%	5,169 $480,000
Q4 2020 Feb 16, 2021	SELL	$79.17 - $111.47 $181,853 - $256,046	-2,297 Reduced 16.63%	11,518 $1.03 Million
Q3 2020 Nov 16, 2020	BUY	$81.91 - $134.94 $777,817 - $1.28 Million	9,496 Added 219.87%	13,815 $1.43 Million
Q2 2020 Aug 13, 2020	BUY	$54.33 - $89.52 $209,061 - $344,472	3,848 Added 816.99%	4,319 $342,000
Q1 2020 May 15, 2020	SELL	$49.34 - $68.76 $117,379 - $163,580	-2,379 Reduced 83.47%	471 $27,000
Q4 2019 Feb 07, 2020	BUY	$51.21 - $59.06 $145,948 - $168,321	2,850 New	2,850 $154,000
Q3 2019 Nov 05, 2019	SELL	$40.6 - $57.2 $4,547 - $6,406	-112 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$39.92 - $53.86 $11,297 - $15,242	-283 Reduced 71.65%	112 $5,000
Q1 2019 May 14, 2019	BUY	$48.23 - $66.16 $19,050 - $26,133	395 New	395 $20,000
Q4 2017 Feb 09, 2018	SELL	$37.77 - $47.75 $54,124 - $68,425	-1,433 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$34.14 - $40.45 $48,922 - $57,964	1,433	1,433 $58,000

Others Institutions Holding EBS

# of Institutions

160

Shares Held

33.8M

Call Options Held

453K

Put Options Held

931K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $442M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Emergent Bio Solutions Inc. Transaction History